3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Ras-mutated Metastatic Colorectal Cancer
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma Metastatic
1
Neoplasms
1
Kidney Neoplasms
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Bevacizumab
7
Capecitabine
4
Cetuximab
3
trifluridine tipiracil drug combination
2
Fluorouracil
2
regorafenib
1
irinotecan sucrosofate
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Panitumumab
1
Nivolumab
1
Liver Transplantation
1
Immune Checkpoint Inhibitors
1
HMPL-013
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
IFL protocol
×
1 year
×
Clear all
No trials found.